HCAII-IN-4
HCAII-IN-4 (Compound 12j) is a potent hCA II inhibitor with an IC50 of 7.78 μM. hCAII-IN-4 also inhibits β-glucuronidase with an IC50 of 773.9 μM[1].
Product Specifications
CAS Number
2816080-18-7
UNSPSC
12352005
Target
Carbonic Anhydrase; β-glucuronidase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Cancer; Metabolic Disease; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/hcaii-in-4.html
Solubility
10 mM in DMSO
Smiles
O=C(C(C1C2=CC=CC=C2OCC(C3=O)=CC4=C(O3)C=CC=C4)=C(N)OC(C5=C(O6)C=C(O)C=C5)=C1C6=O)OCC
Molecular Formula
C31H23NO9
Molecular Weight
553.52
References & Citations
[1]Arif N, et al. Synthesis, Biological Evaluation, and In Silico Studies of Novel Coumarin-Based 4 H, 5 H-pyrano [3, 2-c] chromenes as Potent β-Glucuronidase and Carbonic Anhydrase Inhibitors. ACS Omega, 2022.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CA II
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
OR1007388-01 100 mg
2,2'- (1-Benzyl-2-phenylethylidene) bis ((4S) -4-tert-butyl-4,5-dihydro-2-oxazole)
Sign In for Pricing
View Details OR1007388-02 250 mg
2,2'- (1-Benzyl-2-phenylethylidene) bis ((4S) -4-tert-butyl-4,5-dihydro-2-oxazole)
Sign In for Pricing
View Details OR1007388-03 1 g
2,2'- (1-Benzyl-2-phenylethylidene) bis ((4S) -4-tert-butyl-4,5-dihydro-2-oxazole)
Sign In for Pricing
View Details